Income Tax Expense (Benefit) of Zenas BioPharma, Inc. from 31 Dec 2023 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Zenas BioPharma, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2023 to 30 Jun 2025.
  • Zenas BioPharma, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2025 was $20,000.
  • Zenas BioPharma, Inc. annual Income Tax Expense (Benefit) for 2024 was $429,000, a 43% increase from 2023.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Zenas BioPharma, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $20,000 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $205,000 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1

Zenas BioPharma, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $429,000 +$128,000 +43% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
2023 $301,000 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.